Descriptive Analysis of Isatuximab Use Following Prior Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma
暂无分享,去创建一个
R. Orlowski | Sheeba K. Thomas | D. Weber | E. Manasanch | S. Iyer | K. Patel | M. Becnel | G. Kaufman | S. Horowitz | Hans C. Lee